We are live on ! Find out more
LA

LexAurum Advisors Portfolio holdings

AUM $866M
This Fund
S&P 500
This Quarter Est. Return
-0.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$505M
AUM Growth
+$49.7M
Cap. Flow
+$55.4M
Cap. Flow %
10.99%
Top 10 Hldgs %
28.64%
Holding
354
New
39
Increased
197
Reduced
74
Closed
20

Sector Composition

Rank Sector Weight
1 Financials 7.85%
2 Technology 7.56%
3 Healthcare 3.97%
4 Materials 3.36%
5 Consumer Discretionary 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
176
iShares Select Dividend ETF
DVY
$23.5B
$524K 0.1%
3,988
-34
-0.8% -$4.63K
XLK icon
177
State Street Technology Select Sector SPDR ETF
XLK
$115B
$523K 0.1%
4,502
GRMN
178
Garmin
GRMN
$56.7B
$517K 0.1%
2,507
+6
+0.2% +$1.18K
AME icon
179
Ametek
AME
$55.4B
$500K 0.1%
2,773
+160
+6% +$29.1K
SLB icon
180
SLB Ltd
SLB
$73.6B
$499K 0.1%
13,008
+298
+2% +$12.5K
WBA
181
DELISTED
Walgreens Boots Alliance
WBA
$490K 0.1%
52,552
+485
+0.9% +$4.5K
BUFR icon
182
FT Vest Fund of Buffer ETFs
BUFR
$10.1B
$490K 0.1%
16,089
+8,556
+114% +$259K
VUG icon
183
Vanguard Morningstar Growth ETF
VUG
$220B
$488K 0.1%
+7,134
New +$479K
CFO icon
184
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$417M
$485K 0.1%
7,039
-1,435
-17% -$102K
AEP icon
185
American Electric Power
AEP
$69.6B
$483K 0.1%
5,236
+551
+12% +$53.3K
ISRG icon
186
Intuitive Surgical
ISRG
$127B
$483K 0.1%
925
+98
+12% +$51K
ACN icon
187
Accenture
ACN
$102B
$479K 0.09%
1,362
+67
+5% +$24.1K
AVSE icon
188
Avantis Responsible Emerging Markets Equity ETF
AVSE
$210M
$477K 0.09%
9,466
+1,009
+12% +$53.8K
FHLC icon
189
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$473K 0.09%
7,235
+799
+12% +$55.5K
SCHB icon
190
Schwab US Broad Market ETF
SCHB
$43.2B
$466K 0.09%
20,550
VWO icon
191
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$465K 0.09%
10,551
+4,870
+86% +$226K
PYLD icon
192
PIMCO Multi Sector Bond Active ETF
PYLD
$15B
$460K 0.09%
+17,729
New +$464K
ORCL icon
193
Oracle
ORCL
$374B
$457K 0.09%
2,743
+460
+20% +$81.7K
IWM icon
194
iShares Russell 2000 ETF
IWM
$79.8B
$455K 0.09%
2,058
-90
-4% -$20.5K
VHT icon
195
Vanguard Health Care ETF
VHT
$18.1B
$452K 0.09%
1,780
-46
-3% -$12.4K
IEMG icon
196
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$448K 0.09%
8,573
+3,913
+84% +$217K
PREF icon
197
Principal Spectrum Preferred Securities Active ETF
PREF
$1.77B
$446K 0.09%
23,940
+6,847
+40% +$128K
C icon
198
Citigroup
C
$222B
$442K 0.09%
6,284
+77
+1% +$5.19K
QCOC
199
FT Vest Nasdaq-100 Conservative Buffer ETF - October
QCOC
$64.4M
$440K 0.09%
+21,810
New +$438K
SEEM
200
SEI Select Emerging Markets Equity ETF
SEEM
$603M
$437K 0.09%
+18,739
New +$453K

Similar funds

LexAurum Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, LexAurum Advisors held 354 positions worth $505M, up 11% from $455M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

LexAurum Advisors deployed $55.4M of net new capital in Q4 2024, opening 39 new positions and adding to 197 existing holdings. Its largest new stake was Sherwin-Williams: 46,562 shares worth $15.8M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, down from 8.1% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $2.71M trimmed.

  • LexAurum Advisors's largest Q4 2024 buy was Sherwin-Williams: 46,562 shares worth $15.8M.
  • LexAurum Advisors added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $4.98M increase.
  • LexAurum Advisors's biggest Q4 2024 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $2.71M.
  • LexAurum Advisors fully exited Tortoise North American Pipeline ETF in Q4 2024, selling an estimated $2.09M.
  • LexAurum Advisors's ten largest holdings make up 29% of its $505M portfolio in Q4 2024.
  • LexAurum Advisors opened 39 new positions and closed 20 in Q4 2024.
  • LexAurum Advisors's portfolio value rose 11% quarter-over-quarter to $505M.

Based on LexAurum Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.